https://www.freepressjournal.in/mumbai/tata-memorial-study-finds-ultra-low-dose-immunotherapy-improves-survival-cuts-cancer-treatment-costs
A Phase III trial by Tata Memorial Hospital found that ultra-low dose immunotherapy significantly improved survival and quality of life in relapsed cancer...
low dose immunotherapytata memorialstudy findsultraimproves